Clinical Trial Update: Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating adding buprenorphine at analgesic doses to treat severe suicidal ideation during a major depressive episode; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Suicidal Ideation, Major Depressive Episode | Phase 3 | Status: RECRUITING